by John Conrad | Mar 26, 2020 | COVIDFDA
There has been a lot of coverage about the shortage of N95 masks. Below is a quick breakdown of the regulatory oversight of N95 masks and how the FDA and CDC are working together. The majority of N95 respirators are manufactured for use in the construction or...
by John Conrad | Mar 26, 2020 | COVID, Member News
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it, in partnership with IllinoisGovernor JB Pritzker, has provided $500,000 to the Illinois COVID-19 Response Fund and $500,000 to the Illinois Biotechnology Innovation Organization (iBIO) Institute’s...
by John Conrad | Mar 26, 2020 | COVID, Policy News
Title-By-Title Summary Prepared By The Office Of Vice Chairman Leahy (D-Vt.) The appropriations division of the Senate’s bipartisan coronavirus aid and economic relief agreement contains $330 billion in new funding to address the needs of the American people as we...
by John Conrad | Mar 25, 2020 | COVID, iBIO News
Coordinating medical supply donations and funds to support the healthcare workers on the front lines combating the COVID-19 pandemic. We’re calling on the life sciences community to donate lab, testing, and diagnostics supplies, personal protection equipment (PPE),...
by John Conrad | Mar 23, 2020 | COVID, iBIO News
Illinois is facing a global pandemic that is impacting our residents and businesses. In order to meet this challenge, Illinois’ innovative biotech companies and state-of-the art manufacturers are forming a partnership with the State of Illinois in order to ramp up...
by John Conrad | Mar 20, 2020 | COVID, iBIO News
Today Governor Pritzker announced a “Stay in Home” order restricting all residents to their homes, with few exceptions.The order will be effective March 21st at 5pm and last until at least until the evening of April 7. The order allows residents to leave their homes...
